Literature DB >> 8302590

In vitro reconstruction of tumour initiation in a human epithelium.

J A Bond1, F S Wyllie, J Rowson, A Radulescu, D Wynford-Thomas.   

Abstract

Knowledge of tumour initiation in human epithelia is limited by sample availability and difficulty in experimental manipulation of human cells. The thyroid is a useful model since, in addition to multiple tumour stages, it presents two distinct 'pathways' of tumorigenesis: 'follicular' tumours, in which ras oncogene mutations occur at high frequency and 'papillary' tumours, associated with ret (or trk) activation. We have used these observations to reconstruct early thyroid tumorigenesis, using amphotropic retroviral vectors. When introduced into normal thyroid epithelial cells, mutant ras induces self-limiting growth of well-demarcated, differentiated colonies--a phenotype consistent with follicular adenoma. Activated ret on the other hand induces smaller, poorly-demarcated colonies with a morphology consistent with early papillary tumours. Mutant p53--which occurs only in the latest stages of thyroid cancer--was without effect. Our results provide the first direct experimental evidence in a human epithelium for alternative initiating oncogenes and their determination of the subsequent 'direction' of tumour development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302590

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

1.  Nuclear envelope irregularity is induced by RET/PTC during interphase.

Authors:  Andrew H Fischer; Panya Taysavang; Sissy M Jhiang
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 2.  Coding Molecular Determinants of Thyroid Cancer Development and Progression.

Authors:  Veronica Valvo; Carmelo Nucera
Journal:  Endocrinol Metab Clin North Am       Date:  2018-12-23       Impact factor: 4.741

Review 3.  Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

4.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.

Authors:  L V Owens; L Xu; G A Dent; X Yang; G C Sturge; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

5.  Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis.

Authors:  J A Bond; M F Haughton; J M Rowson; P J Smith; V Gire; D Wynford-Thomas; F S Wyllie
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 6.  Novel treatments for anaplastic thyroid carcinoma.

Authors:  Silvia Martina Ferrari; Giusy Elia; Francesca Ragusa; Ilaria Ruffilli; Concettina La Motta; Sabrina Rosaria Paparo; Armando Patrizio; Roberto Vita; Salvatore Benvenga; Gabriele Materazzi; Poupak Fallahi; Alessandro Antonelli
Journal:  Gland Surg       Date:  2020-01

Review 7.  Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.

Authors:  Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 8.  Molecular pathogenesis and mechanisms of thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

Review 9.  RAS mutations in thyroid cancer.

Authors:  Gina M Howell; Steven P Hodak; Linwah Yip
Journal:  Oncologist       Date:  2013-07-19

10.  RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.

Authors:  Giuliana Cassinelli; Enrica Favini; Debora Degl'Innocenti; Alessandro Salvi; Giuseppina De Petro; Marco A Pierotti; Franco Zunino; Maria Grazia Borrello; Cinzia Lanzi
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.